Neonatal streptozotocin-induced glucose intolerance: Different consequences in Lyon normotensive and hypertensive rats

Journal of Hypertension

Volumn 25, Issue 2, 2007, Pages 429-438

  Emonnot, Léa ^a   Cohen, Richard ^a   Lo, Ming ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Diabetes; Dyslipidemia; Hypertension; Proteinuria

Indexed keywords

ALBUMIN; CHOLESTEROL; GLUCOSE; LIPID; PROTEIN; STREPTOZOCIN; TRIACYLGLYCEROL;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HYPERTENSION; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RAT STRAIN; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; GLYCOSURIA; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; POLYURIA; PROTEINURIA; RATS; RATS, INBRED SHR;

EID: 33846108792     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3280115bd2     Document Type: Article

References (45)

1. Jarrett RJ. Hypertension in diabetic patients and differences between insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1989; 13:14-16.
2. Poulsen PL, Hansen KW, Mogensen CE. Ambulatory blood pressure in the transition from normo- to microalbuminuria A longitudinal study in IDDM patients. Diabetes 1994; 43:1248-1253.
3. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 1996; 335:1636-1642.
4. Kadowaki S, Taminato T, Chiba T, Goto Y, Nozawa M, Seino Y, et al. Somatostatin release from the isolated, perfused diabetic rat pancreas: inverse relationship between pancreatic somatostatin and insulin. Diabetes 1980; 29:960-963.
5. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, et al. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993; 4:40-49.
6. Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 2001; 133:687-694.
7. Palm F, Ortsater H, Hansell P, Liss P, Carlsson PO. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab Res Rev 2004; 20:452-459.
8. Nicholas SB, Mauer M, Basgen JM, Aguiniga E, Chon Y. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats. Am J Nephrol 2004; 24:549-556.
9. Bonner-Weir S, Trent DF, Honey RN, Weir GC. Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes 1981; 30:64-69.
10. Halban PA, Bonner-Weir S, Weir GC. Elevated proinsulin biosynthesis in vitro from a rat model of non-insulin-dependent diabetes mellitus. Diabetes 1983; 32:277-283.
11. Weir GC, Clore ET, Zmachinski CJ, Bonner-Weir S. Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes 1981; 30:590-595.
12. Giroix MH, Portha B, Kergoat M, Bailbe D, Picon L. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes A study with the perfused pancreas. Diabetes 1983; 32:445-451.
13. Permutt MA, Kakita K, Malinas P, Karl I, Bonner-Weir S, Weir G, Giddings SJ. An in vivo analysis of pancreatic protein and insulin biosynthesis in a rat model for non-insulin-dependent diabetes. J Clin Invest 1984; 73:1344-1350.
14. Maloff BL, Boyd BK. Physiologic and cellular insulin action in a glucose-intolerant model of type 2 (non-insulin-dependent) diabetes in rats. Diabetologia 1986; 29:295-300.
15. Tsuji K, Taminato T, Usami M, Ishida H, Kitano N, Fukumoto H, Koh G. Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model. Metabolism 1988; 37:1040-1044.
16. Blondel O, Bailbe D, Portha B. Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozotocin as neonates. Diabetes 1989; 38:610-617.
17. Portha B, Serradas P. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin. Am J Med 1991; 90 (Suppl 1):15S-21S.
18. Kergoat M, Portha B. In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozocin Assessment with the insulin-glucose clamp technique. Diabetes 1985; 34:1120-1126.
19. Vincent M, Boussairi EH, Cartier R, Lo M, Sassolas A, Cerutti C, et al. High blood pressure and metabolic disorders are associated in the Lyon hypertensive rat. J Hypertens 1993; 11:1179-1185.
20. Vincent M, Cartier R, Privat P, Benzoni D, Samani NJ, Sassard J. Major cardiovascular risk factors in Lyon hypertensive rats A correlation analysis in a segregating population. J Hypertens 1996; 14:469-474.
21. 2 and renal functions in the Lyon hypertensive rat. Am J Physiol Regul Integr Comp Physiol 1994; 266:R1530-R1536.
22. Florin M, Lo M, Liu L, Sassard J. Salt sensitivity in genetically hypertensive rats of the Lyon strain. Kidney Int 2001; 59:1865-1872.
23. Bertram D, Blanc-Brunat N, Sassard J, Lo M. Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2002; 283:R1041-R1045.
24. Bilusic M, Bataillard A, Tschannen MR, Gao L, Barreto NE, Vincent M, et al. Mapping the genetic determinants of hypertension, metabolic diseases, and related phenotypes in the Lyon hypertensive rat. Hypertension 2004; 44:695-701.
25. Sato T, Nara Y, Kato Y, Yamori Y. Hypertensive diabetic rats: different effects of streptozotocin treatment on blood pressure in adult SHR and in neonatal SHR. Clin Exp Hypertens 1991; 13:981-990.
26. Rumble JR, Doyle AE, Cooper ME. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes. Am J Hypertens 1995; 8:53-57.
27. Bonnet F, Candido R, Carey RM, Casley D, Russo LM, Osicka TM, et al. Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade. J Hypertens 2002; 20:1615-1624.
28. Forbes JM, Bonnet F, Russo LM, Burns WC, Cao Z, Candido R, et al. Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. J Hypertens 2002; 20:985-992.
29. Iwase M, Kikuchi M, Nunoi K, Wakisaka M, Maki Y, Sadoshima S, Fujishima M. A new model of type 2 (non-insulin-dependent) diabetes mellitus in spontaneously hypertensive rats: diabetes induced by neonatal streptozotocin treatment. Diabetologia 1986; 29:808-811.
30. Iwase M, Kikuchi M, Nunoi K, Wakisaka M, Maki Y, Sadoshima S, Fujishima M. Diabetes induced by neonatal streptozotocin treatment in spontaneously hypertensive and normotensive rats. Metabolism 1987; 36:654-657.
31. Iwase M, Nunoi K, Himeno H, Yoshinari M, Kikuchi M, Maki Y, Fujishima M. Susceptibility to neonatal streptozotocin-induced diabetes in spontaneously hypertensive rats. Pancreas 1994; 9:344-348.
32. Reaven GM, Ho H. Low-dose streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism 1991; 40:335-337.
33. Chen C, Hosokawa H, Bumbalo LM, Leahy JL. Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. J Clin Invest 1994; 94:399-404.
34. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC. Similar reduction of first- and second-phase b-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 1989; 38:767-772.
35. Polhill TS, Saad S, Poronnik P, Fulcher GR, Pollock CA. Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure. Am J Physiol Renal Physiol 2004; 287:F268-F273.
36. Pugliese G, Pricci F, Barsotti P, Iacobini C, Ricci C, Oddi G, et al. Development of diabetic nephropathy in the Milan normotensive strain, but not in the Milan hypertensive strain: possible permissive role of hemodynamics. Kidney Int 2005; 67:1440-1452.
37. Korner A, Jaremko G, Eklof AC, Aperia A. Rapid development of glomerulosclerosis in diabetic Dahl salt-sensitive rats. Diabetologia 1997; 40:367-373.
38. Thorens B, Sarkar HK, Kaback HR, Lodish HF. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell 1988; 55:281-290.
39. Rasch R, Mogensen CE. Urinary excretion of albumin and total protein in normal and streptozotocin diabetic rats. Acta Endocrinol 1980; 95:376-381.
40. Pugliese G, Pricci F, Pesce C, Romeo G, Lenti E, Caltabiano V, et al. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes 1997; 46:1198-1206.
41. De Zeeuw D. Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney Int 2004; 66 (Suppl 92):S2-S6.
42. Keane WF. The role of lipids in renal disease: future challenges. Kidney Int 2000; 57 (Suppl 75):S27-S31.
43. Blanco S, Vaquero M, Gomez-Guerrero C, Lopez D, Egido J, Romero R. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension. Am J Hypertens 2005; 18:557-565.
44. Attia DM, Feron O, Goldschmeding R, Radermakers LH, Vaziri ND, Boer P, et al. Hypercholesterolemia in rats induces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type 1 receptor-sensitive mechanism. J Am Soc Nephrol 2004; 15:949-957.
45. Grone HJ, Walli AK, Grone E, Kramer A, Clemens MR, Seidel D. Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int 1990; 37:1449-1459.